Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma

European Journal of Radiology

Volumn 81, Issue 10, 2012, Pages 2746-2753

  Numata, Kazushi ^a   Fukuda, Hiroyuki ^a   Morimoto, Manabu ^a   Kondo, Masaaki ^a   Nozaki, Akito ^a   Oshima, Takashi ^a   Okada, Masahiro ^b   Takebayashi, Shigeo ^a   Maeda, Shin ^c   Tanaka, Katsuaki ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Computed tomography; Contrast enhanced ultrasonography; Fusion imaging; Hepatocellular carcinoma; Radiofrequency ablation

Indexed keywords

IOPAMIDOL; PERFLUBUTANE;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; HUMANS; IOPAMIDOL; LIVER NEOPLASMS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY;

EID: 84865224650     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.11.052     Document Type: Article

References (22)

1. R. Lencioni, D. Cioni, and L. Crocetti Early stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967
2. W.Y. Lau, and E.C. Lai Hepatocellular carcinoma: current management and recent advances Hepatobiliary Pancreat Dis Int 7 2008 237 257
3. S.N. Goldberg, G.S. Gazelle, and Mueller PR Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance Am J Roentgenol 174 2000 323 331
4. M. Sala, J.M. Llovet, and R. Vilana Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma Hepatology 40 2004 1352 1360
5. S.N. Goldberg, C.J. Grassi, and J.F. Cardella Image-guided tumor ablation: standardization of terminology and reporting criteria Radiology 235 2005 728 739
6. S.K. Kim, H.K. Lim, and Y.H. Kim Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings Radiographics 23 2003 107 121
7. H.K. Lim, D. Choi, and W.J. Lee Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT Radiology 221 2001 447 454
8. C.K. Kim, D. Choi, and H.K. Lim Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging Eur J Radiol 56 2005 66 73
9. R. Vilana, L. Bianchi, and M. Varela Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 16 2006 2454 2462
10. W. Luo, K. Numata, and M. Morimoto Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma Eur J Radiol 75 2010 91 97
11. M.J. Dill-Macky, M. Asch, P. Burns, and S. Wilson Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography AJR Am J Roentgenol 186 2006 S287 S295
12. P. Ricci, V. Cantisani, and F. Drudi Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma? Ultraschall Med 30 2009 252 258
13. E.M. Jung, A.G. Schreyer, and D. Schacherer New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results Clin Hemorheol Microcirc 43 2009 57 69
14. K. Numata, W. Luo, and M. Morimoto Contrast-enhanced ultrasound of hepatocellular carcinoma World J Radiol 2 2010 68 82
15. Y. Kunishi, K. Numata, and M. Morimoto Efficacy of fusion imaging combining ultrasonography and hepatobiliary phase of contrast-enhanced MR image with gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid for detecting small hepatocellular carcinoma Am J Roentgenol 198 2012 1 9
16. M. Hirooka, H. Iuchi, and T. Kumagi Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography Am J Roentgenol 186 2006 255 260
17. K. Kudo, F. Moriyasu, and Y. Mine Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system Eur J Radiol 61 2007 324 331
18. Y.L. Wen, M. Kudo, and R.Q. Zheng Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography Am J Roentgenol 181 2003 57 63
19. Y. Kisaka, M. Hirooka, and T. Kumagi Usefulness of contrast enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation Liver Int 26 2006 1241 1247
20. T. Nakazawa, S. Kokubu, and A. Shibuya Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin Am J Roentgenol 188 2007 480 488
21. Y.S. Kim, W.J. Lee, H. Rhim, H.K. Lim, D. Choi, and J.Y. Lee The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion Am J Roentgenol 195 2010 758 765
22. S.H. Kim, S.H. Kim, and J. Lee Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma Am J Roentgenol 192 2009 1675 1681